Clustering data with hclust algorithm for Untargeted Lipidomics for hepatic lipid profile wild type versus knockout (Study ST000683)

C18 NEGATIVE ION MODE (Analysis AN001052)
MetaboliteStructureF1F2
PA 34:0; [M-H]-@6.82ME1900741.00NA
PE 36:1; [M-H]-@7.46ME1901380.611.39
PG 34:3; [M-H]-@4.64ME1901800.631.37
PG 38:4; [M-H]-@6.09ME1901900.621.38
plasmenyl-PE 34:1; [M-H]-@7.18ME1902330.621.38
PE 42:10; [M-H]-@5.81ME1901710.701.30
PG 36:2; [M-H]-@6.03ME1901820.711.29
PG 36:4; [M-H]-@5.46ME1901850.711.29
N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.45ME1900720.661.34
PG 34:2; [M-H]-@5.24ME1901790.691.31
plasmenyl-PE 34:2; [M-H]-@6.76ME1902340.681.32
PG 36:4; [M-H]-@5.00ME1901840.681.32
PG 38:3; [M-H]-@5.81ME1901880.681.32
PG 40:7; [M-H]-@4.98ME1901960.751.25
plasmenyl-PE 42:4; [M-H]-@8.17ME1902490.741.26
PG 38:2; [M-H]-@6.19ME1901870.741.26
FFA(20:1)ME1900570.741.26
FFA(24:3)ME1900670.741.26
lysoPE 18:1; [M-H]-@1.86ME1902220.731.27
PG 36:3; [M-H]-@5.36ME1901830.731.27
PG 38:7; [M-H]-@4.41ME1901930.781.22
PC 36:1; [M-Ac-H]-@7.35ME1900900.781.22
PC 38:2; [M-Ac-H]-@7.53ME1900990.781.22
FFA(24:2)ME1900660.761.24
PG 38:4; [M-H]-@5.43ME1901890.761.24
plasmenyl-PE 38:6; [M-H]-@6.57ME1902450.771.23
PG 44:11; [M-H]-@4.88ME1902030.771.23
PC 38:3; [M-Ac-H]-@7.14ME1901000.771.23
PE 42:6; [M-H]-@7.49ME1901720.771.23
PC 38:7; [M-Ac-H]-@5.62ME1901041.040.96
plasmenyl-PE 38:1; [M-H]-@8.28ME1902401.050.95
PE 36:4; [M-H]-@6.21ME1901411.050.95
PC 38:4; [M-Ac-H]-@6.77ME1901011.050.95
PE 35:4; [M-H]-@6.05ME1901361.050.95
plasmenyl-PE 42:5; [M-H]-@7.90ME1902501.060.94
PE 34:1; [M-H]-@6.87ME1901281.060.94
PC 40:3; [M-Ac-H]-@7.61ME1901091.060.94
PC 37:3; [M-Ac-H]-@6.77ME1900971.060.94
PC 38:5; [M-Ac-H]-@6.37ME1901021.060.94
PG 42:9; [M-H]-@4.87ME1902011.070.93
PG 42:11; [M-H]-@4.20ME1902001.070.93
PE 38:4; [M-H]-@6.89ME1901531.070.93
PE 37:6; [M-H]-@5.97ME1901481.070.93
PC 40:6; [M-Ac-H]-@6.69ME1901111.070.93
PE 35:3; [M-H]-@6.23ME1901351.070.93
PE 38:1; [M-H]-@7.97ME1901501.090.91
PE 38:3; [M-H]-@7.26ME1901521.080.92
PC 40:8; [M-Ac-H]-@5.81ME1901131.080.92
PE 34:2; [M-H]-@6.41ME1901291.080.92
PS 38:6; [M-H]-@5.22ME1902151.001.00
PS 38:4; [M-H]-@6.01ME1902131.001.00
PE 40:7; [M-H]-@6.39ME1901661.001.00
PE 34:3; [M-H]-@5.97ME1901301.001.00
PC 34:3; [M-Ac-H]-@5.84ME1900851.001.00
PC 35:2; [M-Ac-H]-@6.62ME1900881.001.00
PG 44:10; [M-H]-@5.11ME1902021.010.99
PE 40:4; [M-H]-@7.50ME1901631.010.99
PE 38:6; [M-H]-@6.11ME1901551.010.99
PE 38:1; [M-H]-@7.37ME1901491.010.99
PC 40:9; [M-Ac-H]-@5.45ME1901141.010.99
PE 32:1; [M-H]-@6.24ME1901231.010.99
PE 36:3; [M-H]-@6.56ME1901401.020.98
PE 35:0; [M-H]-@7.58ME1901321.020.98
PE 33:2; [M-H]-@6.05ME1901261.020.98
PE 32:2; [M-H]-@5.77ME1901241.020.98
PC 36:4; [M-Ac-H]-@6.16ME1900931.020.98
PC 36:5; [M-Ac-H]-@5.67ME1900941.020.98
PS 40:6; [M-H]-@5.92ME1902171.030.97
PG 42:10; [M-H]-@4.53ME1901991.030.97
PE 39:6; [M-H]-@6.56ME1901601.030.97
PE 40:6; [M-H]-@6.76ME1901651.030.97
PC 40:7; [M-Ac-H]-@6.25ME1901120.991.01
PC 37:2; [M-Ac-H]-@7.26ME1900960.991.01
IS PC 34:0;[M-Ac-H]-ME1900680.991.01
lysoPE 17:0; [M-H]-@2.05ME1902200.991.01
PS 36:4; [M-H]-@5.33ME1902110.981.02
plasmenyl-PE 40:4; [M-H]-@7.73ME1902460.981.02
PG 38:6; [M-H]-@4.74ME1901920.981.02
PC 42:10; [M-Ac-H]-@5.75ME1901150.981.02
PC 32:0; [M-Ac-H]-@6.65ME1900770.981.02
PC 34:0; [M-Ac-H]-@7.28ME1900820.981.02
PE 39:7; [M-H]-@6.08ME1901610.951.05
PC 32:1; [M-Ac-H]-@6.11ME1900780.951.05
PE 38:5; [M-H]-@6.48ME1901540.951.05
PE 42:8; [M-H]-@6.55ME1901740.961.04
PE 32:0; [M-H]-@6.77ME1901220.961.04
FFA(16:0)ME1900520.961.04
PC 42:11; [M-Ac-H]-@5.31ME1901160.961.04
PG 40:5; [M-H]-@5.64ME1901940.971.03
PE 38:7; [M-H]-@5.71ME1901570.971.03
PC 38:6; [M-Ac-H]-@6.01ME1901030.971.03
PC 33:1; [M-Ac-H]-@6.48ME1900800.971.03
PC 36:6; [M-Ac-H]-@5.46ME1900950.971.03
PS 40:4; [M-H]-@6.44ME1902160.921.08
plasmenyl-PE 40:6; [M-H]-@7.20ME1902480.921.08
plasmenyl-PE 38:5; [M-H]-@6.75ME1902440.921.08
FFA(20:0)ME1900560.921.08
PG 40:8; [M-H]-@4.58ME1901970.921.08
plasmenyl-PE 36:5; [M-H]-@6.31ME1902390.931.07
plasmenyl-PE 36:1; [M-H]-@7.76ME1902350.931.07
PG 36:1; [M-H]-@6.45ME1901810.931.07
PG 34:1; [M-H]-@5.85ME1901780.931.07
PE 40:7; [M-H]-@7.56ME1901670.931.07
PE 35:1; [M-H]-@7.14ME1901330.931.07
PC 32:2; [M-Ac-H]-@5.65ME1900790.931.07
lysoPE 20:4; [M-H]-@1.28ME1902290.931.07
lysoPE 20:1; [M-H]-@2.66ME1902260.931.07
CerP 34:1; [M-H]-@5.87ME1900510.931.07
lysoPE 16:1; [M-H]-@1.22ME1902190.931.07
plasmenyl-PE 36:2; [M-H]-@7.34ME1902360.941.06
PE 36:0; [M-H]-@7.87ME1901370.941.06
FFA(18:0)ME1900530.941.06
PC 40:4; [M-Ac-H]-@7.49ME1901100.941.06
plasmenyl-PE 40:5; [M-H]-@7.46ME1902470.891.11
PC 36:2; [M-Ac-H]-@6.90ME1900910.891.11
PC 36:3; [M-Ac-H]-@6.42ME1900920.891.11
plasmenyl-PE 38:4; [M-H]-@7.23ME1902430.911.09
PG 40:9; [M-H]-@4.19ME1901980.911.09
PE 36:4; [M-H]-@7.57ME1901420.911.09
PC 37:4; [M-Ac-H]-@6.55ME1900980.911.09
PC 34:2; [M-Ac-H]-@6.23ME1900840.911.09
lysoPE 20:3; [M-H]-@1.64ME1902280.911.09
FFA(18:1)ME1900540.911.09
FFA(22:0)ME1900600.911.09
PE 39:3; [M-H]-@7.49ME1901580.901.10
PE 38:2; [M-H]-@7.53ME1901510.901.10
PE 36:2; [M-H]-@7.01ME1901390.901.10
PC 42:5; [M-Ac-H]-@7.56ME1901170.901.10
FFA(22:1)ME1900610.901.10
FFA(18:2)ME1900550.901.10
FFA(20:4) Arachidonic acidME1900590.901.10
FFA(24:0)ME1900640.821.18
lysoPE 22:4; [M-H]-@1.86ME1902300.821.18
PE 34:0; [M-H]-@7.29ME1901270.811.19
PC 44:12; [M-Ac-H]-@5.64ME1901210.811.19
PC 30:1; [M-Ac-H]-@5.49ME1900760.811.19
PC 42:7; [M-Ac-H]-@6.85ME1901190.811.19
PE 40:8; [M-H]-@5.99ME1901680.791.21
PS 38:5; [M-H]-@5.45ME1902140.801.20
PG 38:5; [M-H]-@5.10ME1901910.801.20
PC 33:2; [M-Ac-H]-@6.04ME1900810.801.20
PA 34:2; [M-H]-@6.30ME1900750.801.20
lysoPE 22:6; [M-H]-@1.24ME1902320.801.20
FFA(22:3)ME1900630.801.20
lysoPE 22:5; [M-H]-@1.58ME1902310.801.20
PE 36:5; [M-H]-@5.89ME1901430.831.17
PC 42:8; [M-Ac-H]-@6.41ME1901200.831.17
N-(hexadecanoyl)-sphing-4-enine; [M-H]-@6.83ME1900710.831.17
lysoPE 18:2; [M-H]-@1.32ME1902230.831.17
FFA(20:2)ME1900580.831.17
lysoPE 18:0; [M-H]-@2.49ME1902210.831.17
plasmenyl-PE 38:3; [M-H]-@7.56ME1902420.841.16
PG 40:6; [M-H]-@5.44ME1901950.841.16
lysoPE 19:0; [M-H]-@3.04ME1902240.841.16
PG 36:5; [M-H]-@4.52ME1901860.841.16
N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.47ME1900690.881.12
PG 34:0; [M-H]-@6.34ME1901770.881.12
plasmenyl-PE 36:4; [M-H]-@6.71ME1902380.871.13
PE 42:7; [M-H]-@6.99ME1901730.871.13
PE 41:4; [M-H]-@7.62ME1901700.871.13
PC 35:1; [M-Ac-H]-@7.09ME1900870.871.13
PE 38:6; [M-H]-@7.64ME1901560.871.13
N-(eicosanoyl)-sphing-4-enine; [M-H]-@7.96ME1900700.851.15
lysoPE 20:2; [M-H]-@2.08ME1902270.851.15
lysoPE 16:0; [M-H]-@1.69ME1902180.851.15
FFA(22:2)ME1900620.851.15
FFA(24:1)ME1900650.851.15
PS 37:4; [M-H]-@5.64ME1902120.861.14
N-(tetracosanoyl)-sphing-4-enine; [M-H]-@8.92ME1900730.861.14
PC 34:1; [M-Ac-H]-@6.71ME1900830.861.14
PC 34:4; [M-Ac-H]-@5.57ME1900861.110.89
PG 44:12; [M-H]-@4.44ME1902041.130.87
plasmenyl-PE 42:6; [M-H]-@7.74ME1902511.120.88
plasmenyl-PE 36:3; [M-H]-@6.96ME1902371.120.88
PG 33:0; [M-H]-@6.06ME1901761.120.88
PE 37:5; [M-H]-@6.17ME1901471.120.88
PC 39:4; [M-Ac-H]-@7.17ME1901051.120.88
PE 37:2; [M-H]-@7.29ME1901451.120.88
PE 35:2; [M-H]-@6.71ME1901341.170.83
PI 36:4; [M-H]-@5.24ME1902071.180.82
PC 39:5; [M-Ac-H]-@6.71ME1901061.180.82
PC 42:6; [M-Ac-H]-@7.42ME1901181.180.82
PE 40:9; [M-H]-@5.54ME1901691.160.84
PE 40:2; [M-H]-@8.00ME1901621.140.86
plasmenyl-PE 38:2; [M-H]-@7.89ME1902411.150.85
PC 39:6; [M-Ac-H]-@6.43ME1901071.150.85
PE 34:4; [M-H]-@5.71ME1901311.150.85
PI 36:2; [M-H]-@5.94ME1902061.280.72
PE 33:1; [M-H]-@6.58ME1901251.230.77
PI 38:4; [M-H]-@5.87ME1902091.230.77
CL 76:10; [M-2H](2-)@9.07ME1900501.200.80
PI 38:5; [M-H]-@5.40ME1902101.210.79
PE 39:4; [M-H]-@7.22ME1901591.210.79
PC 39:7; [M-Ac-H]-@5.99ME1901081.210.79
PE 37:4; [M-H]-@6.72ME1901461.210.79
CL 72:7; [M-2H](2-)@9.09ME1900461.420.58
CL 72:8; [M-2H](2-)@8.92ME1900471.390.61
CL 74:8; [M-2H](2-)@9.18ME1900481.400.60
lysoPE 20:0; [M-H]-@3.48ME1902251.320.68
PI 38:3; [M-H]-@6.09ME1902081.340.66
PE 36:6; [M-H]-@5.53ME1901441.360.64
CL 72:6; [M-2H](2-)@9.30ME1900451.350.65
PG 44:9; [M-H]-@5.47ME1902051.350.65
CL 74:9; [M-2H](2-)@9.03ME1900491.570.43
PC 35:3; [M-Ac-H]-@6.11ME1900891.480.52
PE 40:5; [M-H]-@7.21ME190164NA1.00
PG 32:1; [M-H]-@5.29ME1901750.271.73

Factors:

F1Type:knockout
F2Type:wild type
Data matrix
  logo